Elevation of serum GGT and LDH levels, together with higher BCLC staging are associated with poor overall survival from hepatocellular carcinoma: A retrospective analysis

Discovery Medicine

Volumn 19, Issue 107, 2015, Pages 409-418

  Yang, Zongguo ^a   Ye, Peiyan ^c   Xu, Qingnian ^b,c   Lu, Yunfei ^b,c   Tang, Bozong ^b,c   Wang, Qiang ^b,c   Chen, Shishi ^b,c   Chen, Xiaorong ^b,c  

^a FUDAN UNIVERSITY   (China)

^b Key Lab of Infectious Diseases State Administration of Traditional Chinese Medicine   (China)

^c SHANGHAI PUBLIC HEALTH CLINICAL CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; LOW DENSITY LIPOPROTEIN; SORAFENIB; TUMOR MARKER; GAMMA-GLUTAMYLTRANSFERASE, HUMAN; LACTATE DEHYDROGENASE; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER FUNCTION TEST; MALE; MEDICAL RECORD; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SURVIVAL TIME; AGED; BLOOD; DISEASE FREE SURVIVAL; FEMALE; LIVER TUMOR; MORTALITY; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; L-LACTATE DEHYDROGENASE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84940482970     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977-1010, 2015.
2. AugoffK, Hryniewicz-Jankowska A, Tabola R. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett 358(1):1-7, 2015.
3. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J; EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421-430, 2001.
4. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35(3):519-524, 2002.
5. Carr BI, Pancoska P, Branch RA. Significance of increased serum GGTP levels in HCC patients. Hepatogastroenterology 57(101):869-874, 2010.
6. Carr BI, Guerra V. Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase. Oncology 85(3):153-159, 2013.
7. Chan KM, Lee CF, Wu TJ, Chou HS, Yu MC, Lee WC, Chen MF. Adverse outcomes in patients with postoperative ascites after liver resection for hepatocellular carcinoma. World J Surg 36(2):392-400, 2012.
8. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908-943, 2012
9. Faloppi L, Scartozzi M, Bianconi M, Svegliati Baroni G, Toniutto P, Giampieri R, Del Prete M, De Minicis S, Bitetto D, Loretelli C, D'Anzeo M, Benedetti A, Cascinu S. The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management. BMC Cancer 14:110, 2014.
10. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-687, 2006.
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
12. Galperin MY, Koonin EV. Divergence and convergence in enzyme evolution. J Biol Chem 287(1):21-28, 2012.
13. Hanigan MH. Gamma-glutamyl transpeptidase: redox regulation and drug resistance. Adv Cancer Res 122:103-141, 2014.
14. Jeng KS, Sheen IS, Tsai YC. Gamma-glutamyl transpeptidase messenger RNA may serve as a diagnostic aid in hepatocellular carcinoma. Br J Surg 88(7):986-987, 2001.
15. Johnson PJ. The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 5(1):145-159, 2001.
16. Kuroda H, Kasai K, Kakisaka K, Yasumi Y, Kataoka K, Ushio A. Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma. Hepatol Res 40(5):550-554, 2010.
17. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV. inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 107(5):2037-2042, 2010.
18. Li JX, Wu H, Huang JW, Zeng Y. The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma. J Formos Med Assoc 111(9):510-515, 2012.
19. Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41(4):707-716, 2005.
20. Miao P, Sheng S, Sun X, Liu J, Huang G. Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB Life 65(11):904-910, 2013.
21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646-649, 1973.
22. Rich N, Singal AG. Hepatocellular carcinoma tumour markers: current role and expectations. Best Pract Res Clin Gastroenterol 28(5):843-853, 2014.
23. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 136(2):477-85.e11, 2009.
24. Scartozzi M, Faloppi L, Bianconi M, Giampieri R, Maccaroni E, Bittoni A, Del Prete M, Loretelli C, Belvederesi L, Svegliati Baroni G, Cascinu S. The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. PLoS One 7(3):e32653, 2012.
25. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64(5-6):993-998, 2002.
26. Sheen IS, Jeng KS, Tsai YC. Is the expression of gamma-glutamyl transpeptidase messenger RNA an indicator of biological behavior in recurrent hepatocellular carcinoma? World J Gastroenterol 9(3):468-473, 2003.
27. Sheng SL, Liu JJ, Dai YH, Sun XG, Xiong XP, Huang G. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J 279(20):3898-3910, 2012.
28. Shirabe K, Kajiyama K, Harimoto N, Masumoto H, Fukuya T, Ooya M, Maehara Y. Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion. World J Gastroenterol 15(21):2632-2637, 2009.
29. Singhal A, Jayaraman M, Dhanasekaran DN, Kohli V. Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence. Crit Rev Oncol Hematol 82(2):116-140, 2012.
30. Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 29(4):502-510, 2009.
31. Tsutsumi M, Sakamuro D, Takada A, Zang SC, Furukawa T, Taniguchi N. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma. Hepatology 23(5):1093-1097, 1996.
32. West MB, Chen Y, Wickham S, Heroux A, Cahill K, Hanigan MH, Mooers BH. Novel insights into eukaryotic γ-glutamyltranspeptidase 1 from the crystal structure of the glutamate-bound human enzyme. J Biol Chem 288(44):31902-31913, 2013.
33. West MB, Wickham S, Quinalty LM, Pavlovicz RE, Li C, Hanigan MH. Autocatalytic cleavage of human gamma-glutamyl transpeptidase is highly dependent on N-glycosylation at asparagine 95. J Biol Chem 286(33):28876-28888, 2011.
34. Yang Z, Zhuang L, Szatmary P, Wen L, Sun H, Lu Y, Xu Q, Chen X. Upregulation of Heat Shock Proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in Tumour Tissues Is Associated with Poor Outcomes from HBV-Related Early-Stage Hepatocellular Carcinoma. Int J Med Sci 12(3):256-263, 2015.
35. Yu MC, Chan KM, Lee CF, Lee YS, Eldeen FZ, Chou HS, Lee WC, Chen MF. Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg 15(8):1440-1449, 2011.
36. Zhang JB, Chen Y, Zhang B, Xie X, Zhang L, Ge N, Ren Z, Ye SL. Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Eur J Gastroenterol Hepatol 23(9):787-793, 2011.
37. Zhao J, Yan T, Bi X, Zhao H, Huang Z, Zhou J, Li Z, Li C, Cai J. Correlation of carcinoembryonic antigen with prognosis of hepatocellular carcinoma after hepatectomy. Zhonghua Zhong Liu Za Zhi (in Chinese) 36(6):430-434, 2014.